http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3945136-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d12b35c0dd9adfb167b3b4f383afe93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_845dee65a3b9073bfd5dd429d700d189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27c3980c665fca4652b322421eacff14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8563f33570305b21927a30b1a4b7b5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2eb97d8c773024d2555452a42ae9d4d5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
filingDate 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_052cf47738ae216519f16db1eb75f912
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83cb890edde5de4fa893f6ad1e09cda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeee5e5c6dba6077333adb36dd2fed22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa083465be8e68f6690ed0faf19d186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03d449586cbee351c778a3cffc85e338
publicationDate 2022-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3945136-A1
titleOfInvention In vitro method for the prognosis of patients suffering from her2-positive breast cancer
abstract The present invention refers to an in vitro method for the prognosis of patients suffering from HER2+ breast cancer and/or for the prediction of response to anti-HER2 therapies in patients suffering from HER2+ breast cancer.
priorityDate 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2133433-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020071768-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013177245-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396349

Total number of triples: 50.